Early next year, a radical new treatment for Parkinson’s disease involving tissue transplants will receive its first trial with patients – including a group from the UK.
Stem cells grown in the laboratory and transformed into nerve cells will be used to replace those destroyed by the disease. It is hoped that these will stop the spread of debilitating symptoms.
“It has taken a long time to get to this stage but hopefully results from these trials will mean that, in a few years, we might be able to offer tissue transplants as standard treatments for Parkinson’s,” said Prof Roger Barker, of Cambridge University. “It is certainly a promising approach.”
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3IDPIBLBBRON7ECX6O4ZRI4F4Y.jpg)
A U.S. appeals court on Monday shot down Johnson & Johnson's (JNJ.N) attempt to offload tens...
The Affordable Care Act health insurance marketplaces just hit a record: 16.3 million people signed up...
